Personalis, Inc. (PSNL) Stock: Is This Biotechnology Stock Worth Your Time?

Genprex GNPX Stock News

Personalis, Inc. (PSNL) is working its way for to the bottom in the market in today’s trading session. The stock, one that is focused in the biotech sector, is presently trading at $10.08 after falling -7.52% so far in today’s session. When it comes to biotechnology companies, there are several factors that have the ability to lead to price movement in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent stories surrounding PSNL:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Oct-24-19 11:00AM Personalis, Inc. to Present at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2019
Oct-08-19 11:00AM Personalis, Inc. to Present at Advances in Immuno-Oncology Congress USA 2019
Sep-26-19 04:05PM Personalis Receives New Order from the VAs Million Veteran Program Total Awarded to Date Now $145M
Sep-20-19 01:11PM What Kind Of Shareholder Owns Most Personalis, Inc. (NASDAQ:PSNL) Stock?
Sep-12-19 04:07PM Personalis Appoints Karin Eastham to Its Board of Directors

However, any time investors are making a decision with regard to investing, prospective investors should look into much more than just news, this is especially the case in the generally speculative biotech space. Here’s what’s happing when it comes to Personalis, Inc..

Returns That PSNL Investors Have Seen

While a move down on a single session, like the move that we’re seeing from Personalis, Inc. might lead to fear in some investors, a single session decline by itself should not be the basis of a decision to, or not to, invest in a company. It’s always important to dig into trends for a period longer than a single session. When it comes to PSNL, below are the returns on investment that investors have experienced:

  • Weekly – In the last 5 trading sessions, PSNL has produced a change in value amounting to -14.21%.
  • Past Month – The return from Personalis, Inc. over the past 30 days has been -31.31%.
  • Past 3 Months – In the last 3 months, the stock has produced a ROI that works out to -43.72%
  • Past Six Months – Throughout the previous six months, investors have seen a change that works out to 0 from the company.
  • This Year So Far – Since the open of this year PSNL has resulted in a return of -64.62%.
  • Annually – Finally, throughout the past full year, we have seen movement that works out to 0 out of PSNL. Over this period, the stock has sold at a high of -68.38% and a low price of -0.88%.

Notable Ratios

Looking at a few ratios having to do with a stock can provide traders an understanding of how dangerous and/or rewarding a pick might be. Here are some of the important ratios to consider when digging into PSNL.

Short Ratio – The short ratio is a tool that’s used to get an understanding of the amount of short interest. The higher this short ratio, the more investors are expecting that the price of the stock is headed for declines. Across the sector, biotech stocks tend to come with a higher short ratio. On the other hand, we also tend to see quite a few short squeezes in the sector. Nonetheless, in relation to Personalis, Inc., the stock’s short ratio amounts to 2.79.

Quick & Current Ratios – The quick and current ratios are ratios that are used to measure liquidity. Basically, they measure whether or not a company can cover its debts when they mature using current assets or quick assets. Because many biotech companies rely on continued support from investors, these ratios can seem upsetting. However, some good picks in the biotech industry come with strong current and quick ratios. As far as PSNL, the quick and current ratios work out to 3.10 and 3.10 respectively.  

Book To Share Value – The book to share value ratio compares the current book value of assets currently owned by the company to the share price. when it comes to Personalis, Inc., that ratio is 3.76.

Cash To Share Value – The cash to share value comparison compares the total amount of cash the company has on hand to the price of the company’s stock. Several early stage biotech companies have a hard time keeping cash on hand. So, if you’re interested in a biotech stock, this is an important ratio to think about. In this case, the cash to share value ratio works out to 5.25.

Analyst Opinions Of Personalis, Inc.

Although it’s rarely a smart idea to unknowingly follow the opinions of analysts, it is a smart idea to consider their analysis when validating your own due diligence before making investment decisions in the biotechnology space. Here are the recent moves that we have seen from analysts when it comes to PSNL.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Sep-26-19 Upgrade BofA/Merrill Neutral → Buy $22
Jul-15-19 Initiated Oppenheimer Outperform $29
Jul-15-19 Initiated Morgan Stanley Overweight $28
Jul-15-19 Initiated Cowen Outperform
Jul-15-19 Initiated BofA/Merrill Neutral $27

What Are Big Money Players Doing With Personalis, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in PSNL, here’s what we’re seeing:

Institutions own 76.60% of the company. Institutional interest has moved by 1.23% over the past three months. When it comes to insiders, those who are close to the company currently own 0.20% percent of PSNL shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

What You Need To Know About Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 31.13M shares of Personalis, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, PSNL has a float of 30.54M.

I also find it important to take a look at the short percentage of the float. Think about it, if a high portion of the float available for trading is sold short, the overall opinion among investors is that the company is headed for a dive. In regard to PSNL, the short percentage of the float is currently 2.84%. Most traders believe that a high short percent of the float would be considered to be anything over 40%. Nonetheless, I have found that a short ratio over 26% is usually a a play that could prove to be very risky.

Financial Performance

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-0.92. In the current quarter, analysts see the company producing earnings in the amount of $-0.25. Over the last 5 years, PSNL has generated revenue in the amount of $0 with earnings coming in at 0. On a quarter over quarter basis, earnings have seen movement of 0.00% and revenue has seen movement of 276.20%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

As a computer, I’m very dependent on human beings. A human built me! Although, my creator made it possible for me to learn on my own, it’s much simpler to learn with the help of feedback from human beings. At the bottom of this article, you will see a comment section. If you’d like for me find other information, evolve the way I communicate, take a look at data from an alternative angle, or just about anything else, I’d like to know. Please take a moment to leave a comment below. I will read your lesson and I will use it to become a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here